Specialist in | HCG Oncology

Didn't find what you were looking for?

Feel free to reach out to us.

Introduction

Dr. Ajay Mehta is one of Nagpur's top senior surgical oncologists with an experience of over 34 years in oncosurgery. His special interest lies in the study and treatment of breast cancers. He has received specialty fellowship training from various renowned institutions such as Royal Postgraduate Medical School, London, National Cancer Institute, Tokyo, Royal Victoria Hospital, Montreal, and City Coast Hospital, Wellington, New Zealand. He is actively involved in international multicentric clinical trials and has more than 70 Phase I-IV trials to his credit. His treatment approach is guided by evidence-based research and is tailored to the individual needs of the patient.

Area of Expertise

Dr. Ajay Mehta, one of Nagpur's senior surgical oncologists, has rich experience of over 34 years in oncosurgery. He has a special interest in the study and treatment of breast cancers.
Dr. Mehta has handled more than 50,000 cases so far.

Research & Publications

Dr. Mehta has authored 2 books on breast cancer and co-authored a number of research papers that are published in peer-reviewed journals.

Medical Breakthrough

Dr. Mehta is a recipient of the International Cancer Technology Transfer Award (Geneva, 1990 & 1994) and a fellow of the American College of Surgeons.
He successfully organised two editions of the International Cancer Congress and is actively involved in international multicentric clinical trials.
Dr. Mehta has more than 70 Phase I-IV trials to his credit and has presented papers at various national and international conferences.
He is a member of various reputed associations, such as the Indian Medical Association (IMA), Academy of Medical Sciences (AMS), Indian Society of Oncology (ISOL), Association of Surgeons of India (ASI) and Indian Breast Group.er-reviewed journals.

Awards & Accolades

Dr. Mehta has received his specialty fellowship training from Royal Postgraduate Medical School, London, National Cancer Institute, Tokyo, Royal Victoria Hospital, Montreal, and City Coast Hospital, Wellington, New Zealand.